LGND - LIGAND PHARMACEUTICALS INC
206.27
-2.680 -1.299%
Share volume: 260,158
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$208.95
-2.68
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-08-2024 | 02-28-2025 | 05-09-2025 | 08-08-2025 | 11-07-2025 | |
| Cash flow financing | 12.182 M | 9.491 M | 55.080 M | 20.388 M | -4.747 M | 14.995 M | 409.645 M | |
| Other financing cash flows | 12.223 M | 9.548 M | 21.260 M | 17.396 M | -4.676 M | 14.997 M | -87.907 M | |
| Cash flow | 27.139 M | -31.954 M | 45.103 M | 10.236 M | -25.298 M | 20.127 M | 69.290 M | |
| Net income | 86.139 M | -51.911 M | -7.172 M | -31.088 M | -42.451 M | 4.847 M | 117.273 M | |
| Depreciation | 8.765 M | 8.853 M | 8.994 M | 8.627 M | 8.770 M | 8.522 M | 8.269 M | |
| Changes in inventories | -2.632 M | 0.000 | 0.000 | 0.000 | 500.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -3.775 M | -54.759 M | -46.507 M | -38.623 M | 4.894 M | -10.667 M | -353.445 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | -501.000 K | -1.966 M | -17.156 M | 2.537 M | 3.149 M | 2.030 M | 2.774 M | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 105.000 K | 408.000 K | 596.000 K | 712.000 K | 214.000 K | 214.000 K | 15.000 K | |
| Cash Change | 27.139 M | -31.954 M | 45.480 M | 8.688 M | -24.318 M | 17.326 M | 74.061 M |